AlphaGrep UK’s Oscar Health OSCR Stock Holding History

AlphaGrep UK’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-35,919	Closed	-$412K	–	897
2026 Q1	$412K	Buy	35,919 +21,584	+151%	+$304K	0.12%	347
2025 Q4	$206K	Buy	+14,335	New	+$248K	0.07%	616

Other funds holding OSCR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AlphaGrep UK's OSCR Position: Q2 2026 in Review

AlphaGrep UK sold out of Oscar Health (OSCR) in Q2 2026, closing a stake of 35,919 shares — an estimated $412K sold.

AlphaGrep UK first reported a position in OSCR in Q4 2025 and held it in 2 quarters. The position peaked at $412K in Q1 2026. 378 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

AlphaGrep UK reported no remaining Oscar Health position as of Q2 2026 after selling out during the quarter.
AlphaGrep UK sold 35,919 Oscar Health shares in Q2 2026, an estimated $412K.
AlphaGrep UK first reported a position in Oscar Health in Q4 2025 and held it in 2 quarters.
AlphaGrep UK's Oscar Health position peaked at $412K in Q1 2026.
378 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.